HEALTH: QUESTIONING EXPERTISE: Deficient evaluation and conflicts of interest

European Parliament - Brussels - Room: JAN 4Q 1

04 March 2010 - 9.00-12.30 & 14.30-17.00

MEP Corinne Lepage, MEP Frédérique Ries and MEP Fiona Hall

Co-organisation:

  1. CRIIGEN - Comité de Recherche et d'Information Indépendantes sur le Génie Génétique
  2. FSC - Fondation Sciences Citoyennes
  3. ENSSER - European Network of Scientists for Social and Environmental Responsibility

Programme

programmBXL.pdf

33 K

Documentation

Pictures and videos of the workshops are posted at the internet page of ALDE (Alliance  of Liberals and Democrats for Europe). To download the presentations, click on the pictures at the right.

Topics:

  1. The example of a controversial industrial product: Bisphenol A

    a) André Cicolella (Institut National de l'Environnement industriel et des risques - INERIS): The case of au Bisphenol A (BPA)

    b) Lisette Van Vliet (Health and Environment Alliance): BisphenolA: Perspective from a European environmental health NGO
  1. The example of a drug, Neurontin

    a) Pierre Chevalier (Catholic University of Leuven): Conflits d’intérêts et désinformation scientifique - A partir de l’exemple du Neurontin® (gabapentine)

    b) Elena Pasca (Fondation Sciences Citoyennes - FSC)
  1. The example of GMOs producing insecticides (MON 863, MON 810)

    a) Marcello Buiatti (University of Florence)

    b) Gilles-Eric Séralini (Comité de Recherche et d'Information Indépendantes sur le génie GENétique - CRIIGEN): These GMOs changing the world
    c) Christoph Then (Testbiotech): Bt-toxin Cry1Ab as produced in MON810 and Bt11: some very basic questions
  1. The example of a pesticide: Roundup

    a) Gilles-Eric Séralini (Comité de Recherche et d'Information Indépendantes sur le génie GENétique - CRIIGEN): Toxicity of Roundup on human cells

    b) François Veillerette (Mouvement pour les Droits et le Respect des Générations Futures - MDRGF)
  1. Industry interest in the advisory bodies for EU health policy

    a) Nina Holland (Corporate Europe Observatory - CEO / Alliance for Lobbying Transparency and Ethics Regulation - ALTER-EU): Industry interests in the advisory bodies for EU health policy